Urothelial cancer in 2017: Changes in expectations for metastatic urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/nrclinonc.2017.184
Abstract: 2017 saw the publication of clinical trial data and the approval of new treatment approaches for metastatic urothelial carcinoma. Pembrolizumab is now a well-established treatment for patients with disease progression after cisplatin, with high-level evidence… read more here.
Keywords: urothelial cancer; cancer 2017; urothelial carcinoma; 2017 changes ... See more keywords